# PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

> **NCT03744975** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 72 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diastolic Dysfunction

## Interventions

- **DRUG:** LCZ 696
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03744975
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2025-08-27
- **Final completion:** 2025-08-27
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744975, "PDD in Type 2 Diabetes w/wo Diastolic Dysfunction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03744975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*